ANZUP 2019 Interviews - Andrew Weickhardt talks with Ian Davis about the ENZAMET study

Talking Urology Podcast - Ein Podcast von Talking Urology

In this ANZUP conference highlight, Andrew Weickhardt chats with Australia’s very own Ian Davis about ANZUP’s successful world leading phase 3 study, ENZAMET. Ian outlines ENZAMET for men with newly diagnosed metastatic hormone naïve prostate cancer and how it differs from the other trials involving second line anti-androgens in this space. Ian also discusses how you might decide between the myriad of treatment options that have now shown effect in the upfront hormone naïve metastatic setting.

Visit the podcast's native language site